Table 1 Means, adjusted mean differences (md, 95% CI) and adjusted p values for differences by age, gender and injury characteristics in m-SCIM-SR total score for functional independence, number of moderate to extreme activity/participation problems, NEFI-S score for environmental barriers to participation and number of health conditions.
m-SCIM-SR total score | No. of activity/participation problems | NEFI-S score | No. of health conditions | |||||
---|---|---|---|---|---|---|---|---|
(range 0–100) | (moderate–extreme) | (range 0–100) | (mild–extreme) | |||||
mean | md (95% CI) | mean | md (95% CI) | mean | md (95% CI) | mean | md (95% CI) | |
Mobility category | ||||||||
Ambulant | 82 | ref | 3.7 | ref | 24.7 | ref | 7.4 | ref |
Motorised or assisted WC | 29 | −48 (−52, −45) | 5 | 1.4 (0.9, 2.0)*** | 43.6 | 19 (15, 23)*** | 9.1 | 1.6 (1.1, 2.2)*** |
Self-operated manual WC | 63 | −20 (−23, −17) | 3.4 | 0.02 (−0.5, 0.5) | 36.7 | 11 (8, 15)*** | 8.1 | 0.7 (0.2, 1.2)** |
p value | – | <0.0001 | <0.0001 | <0.0001 | ||||
Injury level and extent | ||||||||
Complete tetraplegia | 27 | ref | 4.5 | ref | 42.3 | ref | 9.1 | ref |
Complete paraplegia | 60 | 35 (29, 41)*** | 3.7 | −1.0 (−1.7, −0.3)** | 36.9 | −5.1 (−9.5, −0.6)* | 8.2 | −0.9 (−1.6, −0.3)** |
Incomplete tetraplegia | 57 | 32 (26, 38)*** | 4.3 | −0.4 (−1.1, 0.3) | 33 | −9.0 (−14, −4.6)*** | 8.4 | −0.6 (−1.2, 0.04) |
Incomplete paraplegia | 73 | 51 (45, 57)*** | 3.8 | −1.1 (−1.8, −0.4)** | 31.7 | −11 (−16, −6)*** | 7.7 | −1.4 (−2.0, −0.7)*** |
p value | <0.0001 | 0.0003 | <0.0001 | <0.0001 | ||||
Cause of injury | ||||||||
Non-traumatic | 63 | ref | 4.4 | ref | 34.7 | ref | 7.9 | ref |
Traumatic | 61 | −2.7 (−7.2, 1.8) | 3.8 | −0.5 (−1.0, −0.02)* | 33.4 | −1.9 (−5.1, 1.3) | 8.1 | −0.09 (−0.6, 0.4) |
p value | 0.2 | 0.04 | 0.2 | 0.7 | ||||
Injury duration | ||||||||
Up to 5 years | 66 | −2.7 (−5.8, 0.4) | 4 | 0.4 (−0.2, 1.0) | 31.7 | 3.0 (−0.4, 6.5) | 7.7 | −0.14 (−0.66, 0.38) |
6–15 years | 61 | −5.3 (−8.1, -2.6)*** | 3.9 | 0.3 (−0.2, 0.9) | 34.7 | 3.9 (0.8, 6.9)* | 8.2 | 0.08 (−0.4, 0.6) |
16–25 years | 62 | −1.0 (−4.2, 2.3) | 4.1 | 0.4 (−0.2, 1.0) | 34.3 | 2.4 (−1.2, 6.0) | 8.2 | 0.0 (−0.6, 0.6) |
26+ years | 59 | ref | 3.7 | ref | 32.7 | ref | 8.2 | ref |
p value | 0.0005 | 0.4 | 0.09 | 0.8 | ||||
Gender | ||||||||
Female | 59 | ref | 4.4 | ref | 36.1 | ref | 7.9 | ref |
Male | 62 | 3.2 (0.9, 5.6)** | 3.8 | −0.5 (−0.9, −0.06)* | 32.6 | −3.3 (−5.9, −0.7)* | 8.1 | 0.2 (−0.2, 0.6) |
p value | 0.006 | 0.02 | 0.01 | 0.3 | ||||
Age group | ||||||||
18–30 years | 58 | 11 (5.2, 18)*** | 3.2 | −0.6 (−1.7, 0.5) | 38.5 | 11 (4, 18)** | 7.3 | −0.06 (−1.1, 1.0) |
31–45 years | 64 | 10 (5.6, 15)*** | 4.1 | 0.5 (−0.3, 1.4) | 36.4 | 12 (6, 18)*** | 8.4 | 1.0 (0.1, 1.9)* |
46–60 years | 62 | 7.4 (3.0, 12)*** | 4.2 | 0.8 (0.05, 1.6)* | 35.7 | 13 (8, 18)*** | 8.4 | 1.1 (0.3, 1.9)** |
61–75 years | 61 | 5.7 (1.4, 10)*** | 3.7 | 0.2 (−0.6, 1.0) | 31.8 | 8 (3, 13)*** | 7.8 | 0.4 (−0.4, 1.2) |
76+ years | 59 | ref | 3.7 | ref | 23.7 | ref | 7.4 | ref |
p value | <0.0001 | 0.003 | <0.0001 | 0.0003 |